Pellagra and the carcinoid syndrome.
D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008303:Malignant Carcinoid Syndrome / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D008875:Middle Aged; D009536:Niacinamide / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000378:metabolism; D010383:Pellagra / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D014364:Tryptophan / Q000378:metabolism
D004071:Digitalis Glycosides; D004232:Diuretics; D009539:Nicotinic Acids; D009536:Niacinamide; D014364:Tryptophan; D005472:Fluorouracil